Morphic Therapeutic
MORF
Rank 3419
Country USA
Exchange NASDAQ
Currency USD
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 35 GATEHOUSE DRIVE A2, WALTHAM, MA, US
Morphic Therapeutic - Key figures
Market cap 810.16 Million
Revenue 18.91 Million
Profit -67,995,000
P/E Ratio No information
P/s Ratio 42.84
Morphic Therapeutic - Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small molecule integrin therapies for the treatment of autoimmune, cardiovascular, metabolic, fibrosis, and cancer diseases.
The company is headquartered in Waltham, Massachusetts.